Dublin, July 10, 2018 (GLOBE NEWSWIRE) -- The "Human Embryonic Stem Cell (hESC) Research - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research. This report analyzes the Global market for Human Embryonic Stem Cell (hESC) Research in US$ Million. The report profiles 25 companies including many key and niche players such as:

  • Astellas Institute of Regenerative Medicine (US)
  • Asterias Biotherapeutics, Inc. (US)
  • BD Biosciences (US)
  • Cell Cure Neurosciences Ltd. (Israel)
  • Cellular Dynamics International (US)
  • GE Healthcare (UK)
  • MilliporeSigma (US)
  • PerkinElmer, Inc. (US)
  • Reliance Life Sciences Ltd. (India)
  • Research & Diagnostics Systems, Inc. (US)
  • SABiosciences Corp. (US)
  • STEMCELL Technologies, Inc. (Canada)
  • Stemina Biomarker Discovery, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • TATAA Biocenter AB (Sweden)
  • Thermo Fisher Scientific, Inc. (US)
  • UK Stem Cell Bank (UK)
  • ViaCyte, Inc. (US)
  • Vitrolife AB (Sweden)

Key Topics Covered

1. INDUSTRY OVERVIEW Stem Cells Research: A Sunrise Sector in Biotechnology Arena Human Embryonic Stem Cells An Introduction Embryonic Stem Cells Sources and Cell Culture Comparison on Adult and Embryonic Stem Cells Advantages and Drawbacks of Various Stem Cells Human Embryonic Stem Cells The Market Perspective Timeline for Embryonic Stem Cell Research Activities: Major Events from 1963 through 2014 Issues Hindering Development of hESC Research Consideration of Best Translational Pathways Pivotal in Ensuring Growth Of hESCs Ethical Issues and Technical Hurdles Bog Down hESC Research Teratomas No Longer an Impediment to Stem Cell Therapy Development Human Embryonic and Induced Pluripotent Stem Cell Research Trends Human Embryonic Stem Cell Research: Key Statistical Highlights Research Topics on hESC and hiPSC by Number of Papers Published: 2011-2013 Haploid Human Embryonic Stem Cell Line: The New Frontier Human Induced Pluripotent Stem Cells Remains Best Alternative for hESC 2. REGULATORY LANDSCAPE Overview Human Embryonic Stem Cell Regulations in Select Countries Worldwide Intellectual Property: WARF Sword Hangs Over New Patents WARF Fails to Gain Patents in Europe Diversity in Patent Regimes Pose Tremendous Challenges International Divide on Patenting Dents hESC Research 3. HESC APPLICATION AND CLINICAL TRIALS Drug Testing Clinical Applications hESC-derived Cardiomyocytes Helps in Better Identification of Cardiotoxicity hESC-derived Cardiomyocytes Provides Physiological Relevant Model For Testing Drug Toxicity Human Pluripotent Stem Cells Hold Immense Potential in Treating Lung Diseases Liver Cells Derived from hESC Shows Potential Benefits in Enabling Drug Development and Modeling Liver Diseases Researchers Succeed in Creating Human Kidney from hESCs hESC offers Hope for Patients with Spinal Cord Injury hESC to Enable Better treatment of Neurodegenerative Disorders Amyotrophic Lateral Sclerosis (ALS) Huntington disease Parkinson Disease hESC Derivatives Showing Way Forward for Eye-related Disorders Age-related Macular Degeneration (AMD) Stargardt Disease Myopic Macular Degeneration Human Embryonic Stem Cells Provide New Options in Fight against Diabetes Type I Diabetes Mellitus Type II Diabetes Mellitus Human Stem Cells Pioneering Heart Disease Treatment hESC Opens Up New Vistas for Dental Treatment 4. COMPETITIVE LANDSCAPE Overview Select Global Players Involved in Developing hESC and iPSC- based Drugs and Products Astellas Institute of Regenerative Medicine (US) Asterias Biotherapeutics, Inc. (US) BD Biosciences (US) Cell Cure Neurosciences Ltd. (Israel) Cellular Dynamics International (US) GE Healthcare (UK) MilliporeSigma (US) PerkinElmer, Inc. (US) Reliance Life Sciences Ltd. (India) Research & Diagnostics Systems, Inc. (US) SABiosciences Corp. (US) STEMCELL Technologies, Inc. (Canada) Stemina Biomarker Discovery, Inc. (US) Takara Bio, Inc. (Japan) TATAA Biocenter AB (Sweden) Thermo Fisher Scientific, Inc. (US) UK Stem Cell Bank (UK) ViaCyte, Inc. (US) Vitrolife AB (Sweden) 5. REGIONAL MARKET OVERVIEW The United States Market Overview Funding in Human Embryonic Stem Cell Research Showing Steady Increase Stem Cell Research, including hESC, Attract State Funding Policy Framework Structure on hESC Research in the US Scientific Advice Clinical Research Legislative Position of Select US States Human Stem Cell Regulation A Brief Overview on Major Regulations for hESC in the US Ethical Issues Marr hESC Research Market Role of National Academies in Human Embryonic Stem Cell Research in US Embryonic Stem Cell Research Oversight Committees Opposition Continues in Certain States; Oklahoma Vetoes hESC Research in the State Previous Anti-hESC Research Policy Puts the US at a Disadvantage Wisconsin Alumni Research Foundation: An Enduring but Controversial Legacy The Consumer Watchdog versus WARF Case Timeline of Consumer Watchdog versus Wisconsin Alumni Research Foundation Case Impact of WARF versus Consumer Watchdog case on the hESC market Major Clinical Trials Being Undertaken in hESC Research Space A Glance on Select hESC Clinical Trials Underway in the US Europe Market Overview Overview of Legislations on hESC in Europe hESC Research Legislation in Select EU Countries Policy Framework Overview Clinical Research Major Regulations Covering hESC Market on Pan-European Scale A Glance over Key EU Regulations Governing Human Stem Cell Research Major Differences between EU and the US Legislations Europe Readies 80-Billion War Chest for Research Purposes Patent Laws in EU Covering hESCs European Court of Justice's Clarity on Patents to Boost European hESC Research EC's Stand on hESC Research to Aid Further Infusion of Funding Rest of World Asia-Pacific Overview hESC Research in Select Regional Markets China Chinese hESC Industry in Rapid Development Mode Stem Cell Tourism Powering Chinese hESC Research Market Liberal Chinese Cultural Ethos Power hESC Research Government Funding A Major Source in Chinese hESC Research Market Moral, Political and Material Risks Mar Chinese hESC Research Market Public acceptability and Moral Standards Govern Chinese Patent Law Despite flaws, Ethical Guidelines Enables Rapid Development of hESC Research Market India Regenerative Medicine and Stem Cell Biology Gaining Ground in India India Streamlines Stem Cell Research Industry Brief Overview on Major Research Undertakings in Stem Cell Research Korea Stem Cell Research Resumes at a Gradual Pace in Korea Following Years of Hiatus Brazil Brazilian hESC Research Market- An Overview Timeline of Major Historical Events in Brazilian Stem Cell Research The MiHeart Study Project A Case of Successful Initiative Role of Media in Brazilian Stem Cell Therapy Research Field 6. RECENT INDUSTRY ACTIVITY DSMB Grants Approval for Cell Cure Neurosciences' Second Cohort OpRegen Clinical Trial Thermo Fisher Takes Over MTI-GlobalStem Astellas Pharma Acquires Ocata Therapeutics Nutech Mediworld Develops HESC therapy for Type-II Diabetes FDA Grants Fast-Tracks Designation for Cell Cure Neurosciences' OpRegen Takara Bio Completes Acquisition of Cellectis AB 7. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 25 (including Divisions/Subsidiaries 28)

  • The United States (16)
  • Canada (1)
  • Japan (2)
  • Europe (7)
    • The United Kingdom (3)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (1)
  • Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/5...human?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Stem Cells